NO20053133L - Kjemiske forbindelser. - Google Patents
Kjemiske forbindelser.Info
- Publication number
- NO20053133L NO20053133L NO20053133A NO20053133A NO20053133L NO 20053133 L NO20053133 L NO 20053133L NO 20053133 A NO20053133 A NO 20053133A NO 20053133 A NO20053133 A NO 20053133A NO 20053133 L NO20053133 L NO 20053133L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- optionally substituted
- independently selected
- chemical connections
- tebazolyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0227704A GB0227704D0 (en) | 2002-11-28 | 2002-11-28 | Chemical compounds |
GB0310828A GB0310828D0 (en) | 2003-05-10 | 2003-05-10 | Chemical compounds |
PCT/GB2003/005091 WO2004048350A2 (en) | 2002-11-28 | 2003-11-24 | Oxazolidinones as antibacterial agents |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20053133D0 NO20053133D0 (no) | 2005-06-27 |
NO20053133L true NO20053133L (no) | 2005-07-15 |
Family
ID=32395888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053133A NO20053133L (no) | 2002-11-28 | 2005-06-27 | Kjemiske forbindelser. |
Country Status (12)
Country | Link |
---|---|
US (1) | US7498350B2 (ar) |
EP (1) | EP1581524A2 (ar) |
JP (1) | JP2006515601A (ar) |
KR (1) | KR20050084010A (ar) |
AU (1) | AU2003285509A1 (ar) |
BR (1) | BR0316690A (ar) |
CA (1) | CA2507628A1 (ar) |
MX (1) | MXPA05005522A (ar) |
NO (1) | NO20053133L (ar) |
SA (1) | SA04250095A (ar) |
TW (1) | TW200533667A (ar) |
WO (1) | WO2004048350A2 (ar) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL163688A0 (en) | 2002-02-28 | 2005-12-18 | Astrazeneca Ab | 3-Cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and theiruse as antibacterial agents |
BR0308018A (pt) | 2002-02-28 | 2005-01-04 | Astrazeneca Ab | Composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo, pró-droga, método para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hirolisável in vivo, composição farmacêutica, e, processo para a preparação de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo |
JP4607107B2 (ja) * | 2003-07-02 | 2011-01-05 | メルク・シャープ・エンド・ドーム・コーポレイション | シクロプロピル基置換されたオキサゾリジノン抗生物質およびこれらの誘導体 |
KR100854211B1 (ko) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
JP2008500318A (ja) * | 2004-05-25 | 2008-01-10 | アストラゼネカ アクチボラグ | 抗菌剤としての3−{4−(ピリジン−3−イル)フェニル}−5−(1h−1,2,3−トリアゾール−1−イルメチル)−1,3−オキサゾリジン−2−オン |
WO2007023507A2 (en) * | 2005-06-20 | 2007-03-01 | Wockhardt Limited | Oxazolidinones bearing antimicrobial activity composition and methods of preparation |
CA2664572C (en) | 2006-09-25 | 2015-06-16 | Wockhardt Research Centre | Substituted piperidinophenyl oxazolidinones |
WO2008069619A1 (en) * | 2006-12-08 | 2008-06-12 | Legochem Bioscience Ltd. | Novel oxazolidinone derivatives, process for preparing thereof and pharmaceutical composition containing the same |
JP5236246B2 (ja) * | 2007-10-18 | 2013-07-17 | 株式会社クラレ | スルホニルハライド誘導体の製造方法 |
JP5352387B2 (ja) * | 2008-09-02 | 2013-11-27 | 株式会社クラレ | スルトン誘導体の製造方法 |
MX2011003820A (es) | 2008-10-10 | 2011-06-16 | Trius Therapeutics | Metodos para preparar oxazolidinonas y composiciones que las contienen. |
SG10201500207QA (en) | 2009-02-03 | 2015-03-30 | Merck Sharp & Dohme | Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate |
US8580767B2 (en) | 2009-05-28 | 2013-11-12 | Trius Therapeutics, Inc. | Oxazolidinone containing dimer compounds, compositions and methods to make and use |
KR101128029B1 (ko) | 2010-03-08 | 2012-03-29 | 주식회사 레고켐 바이오사이언스 | (r)-3-(3-플루오로-4-(1-메틸-5,6-다이하이드로-1,2,4-트리아진-4(1h)-일)페닐)-5-(치환된 메틸)옥사졸리딘-2-온 유도체의 제조방법 |
FR2975990B1 (fr) * | 2011-06-01 | 2013-05-24 | Rhodia Operations | Procede de preparation d'un compose organique fluore |
TW201609651A (zh) | 2013-11-12 | 2016-03-16 | 陶氏農業科學公司 | 用於氟化化合物之過程(一) |
BR102014028164A2 (pt) | 2013-11-12 | 2015-09-08 | Dow Agrosciences Llc | processo para fluoração de compostos |
BR102014028162A2 (pt) | 2013-11-12 | 2015-09-08 | Dow Agrosciences Llc | processo para fluoração de compostos |
KR101561964B1 (ko) | 2013-11-15 | 2015-10-20 | 한국과학기술연구원 | 옥사졸리디논 화합물 및 이를 포함하는 c형 간염 예방 또는 치료용 약학 조성물 |
WO2016061772A1 (en) | 2014-10-22 | 2016-04-28 | Merck Sharp & Dohme Corp. | Nargenicin compounds and uses thereof as antibacterial agents |
TWI726900B (zh) | 2015-08-04 | 2021-05-11 | 美商陶氏農業科學公司 | 用於氟化化合物之過程 |
KR101855334B1 (ko) * | 2015-12-11 | 2018-06-08 | 에스티팜 주식회사 | 옥사졸리디논 유도체의 중간체 제조방법 |
WO2019118311A1 (en) | 2017-12-13 | 2019-06-20 | Merck Sharp & Dohme Corp. | Pharmaceutical compositions of tedizolid phosphate |
WO2019173548A1 (en) * | 2018-03-07 | 2019-09-12 | Cyclerion Therapeutics, Inc. | Process for preparing soluble guanylate cyclase stimulators |
MX2022016063A (es) | 2020-06-18 | 2023-04-11 | Akagera Medicines Inc | Compuestos de oxazolidinona, composiciones de liposomas que comprenden compuestos de oxazolidinona y metodos de uso de los mismos. |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0009803D0 (en) * | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
EP1289984A4 (en) * | 2000-06-05 | 2004-11-24 | Dong A Pharm Co Ltd | NEW OXAZOLIDE DERIVATIVES AND A METHOD FOR THEIR PRODUCTION |
US20020115669A1 (en) | 2000-08-31 | 2002-08-22 | Wiedeman Paul E. | Oxazolidinone chemotherapeutic agents |
JP2004531518A (ja) | 2001-04-07 | 2004-10-14 | アストラゼネカ アクチボラグ | スルホンイミド基を含有する、抗生物質としてのオキサゾリジノン |
KR20040044886A (ko) * | 2001-09-11 | 2004-05-31 | 아스트라제네카 아베 | 항균제로서의 옥사졸리디논 및(또는) 이속사졸린 |
GB2396350A (en) | 2001-10-25 | 2004-06-23 | Astrazeneca Ab | Aryl substituted oxazolidinones with antibacterial activity |
BR0308018A (pt) * | 2002-02-28 | 2005-01-04 | Astrazeneca Ab | Composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo, pró-droga, método para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hirolisável in vivo, composição farmacêutica, e, processo para a preparação de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo |
IL163688A0 (en) | 2002-02-28 | 2005-12-18 | Astrazeneca Ab | 3-Cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and theiruse as antibacterial agents |
WO2004048392A1 (en) | 2002-11-28 | 2004-06-10 | Astrazeneca Ab | Oxazolidinone and / or isoxazoline derivatives as antibacterial agents |
GB0227701D0 (en) | 2002-11-28 | 2003-01-08 | Astrazeneca Ab | Chemical compounds |
-
2003
- 2003-11-24 WO PCT/GB2003/005091 patent/WO2004048350A2/en active Application Filing
- 2003-11-24 BR BR0316690-2A patent/BR0316690A/pt not_active IP Right Cessation
- 2003-11-24 CA CA002507628A patent/CA2507628A1/en not_active Abandoned
- 2003-11-24 KR KR1020057009626A patent/KR20050084010A/ko not_active Application Discontinuation
- 2003-11-24 US US10/536,687 patent/US7498350B2/en not_active Expired - Fee Related
- 2003-11-24 MX MXPA05005522A patent/MXPA05005522A/es unknown
- 2003-11-24 JP JP2005510254A patent/JP2006515601A/ja active Pending
- 2003-11-24 EP EP03778506A patent/EP1581524A2/en not_active Withdrawn
- 2003-11-24 AU AU2003285509A patent/AU2003285509A1/en not_active Abandoned
-
2004
- 2004-04-01 TW TW093109104A patent/TW200533667A/zh unknown
- 2004-04-28 SA SA04250095A patent/SA04250095A/ar unknown
-
2005
- 2005-06-27 NO NO20053133A patent/NO20053133L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004048350A2 (en) | 2004-06-10 |
SA04250095A (ar) | 2005-12-03 |
MXPA05005522A (es) | 2005-07-25 |
US20060116386A1 (en) | 2006-06-01 |
US7498350B2 (en) | 2009-03-03 |
WO2004048350A3 (en) | 2004-10-21 |
JP2006515601A (ja) | 2006-06-01 |
TW200533667A (en) | 2005-10-16 |
AU2003285509A1 (en) | 2004-06-18 |
EP1581524A2 (en) | 2005-10-05 |
CA2507628A1 (en) | 2004-06-10 |
BR0316690A (pt) | 2005-10-18 |
NO20053133D0 (no) | 2005-06-27 |
KR20050084010A (ko) | 2005-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053133L (no) | Kjemiske forbindelser. | |
NO20052534L (no) | Oksazolidinon- og/eller isokazolinderivater som antibakterielle stoffer | |
NO20062269L (no) | Pyridin-karboksylsyrederivater som glucokinasemodulatorer | |
NO2015020I2 (no) | Ceritinib eller et farmasøytisk akseptabelt salt derav | |
NO20070032L (no) | Hetroarylbenzamid-derivater for anvendelse som GLK-aktivatorer ved behandling av diabetes | |
DK0958296T3 (da) | Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme | |
NO20066055L (no) | Pyridinderivater | |
NO20063446L (no) | Tiazolderivater | |
NO20062491L (no) | Benzoksazinderivter og deres anvendelse | |
NO20073926L (no) | Pyrazolforbindelser som modulerer aktivitet av CDK-, GSK- og aurorakinaser | |
NO20073960L (no) | Pyrazolderivater for inhibering av CDK og GSK | |
ATE241617T1 (de) | Pyrimidinverbindungen | |
NO20052038L (no) | Ny adeninforbindelse og anvendelse derav | |
NO20065012L (no) | Tetrahydronaftyridin-derivater og fremgangsmate for fremstilling av disse | |
TW200640900A (en) | 1-(2h)-isoquinolone derivative | |
NO20050666L (no) | 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer | |
ATE377420T1 (de) | Phenylalkansäure- und phenyloxyalkansäure- derivate als hppar aktivatore | |
CY1106358T1 (el) | Νεοι δικυκλικοι αναστολεις της ορμονοευαισθητης λιπασης | |
NO20070157L (no) | Substituerte diketopiperaziner som oksytocinantagonister | |
NO20080110L (no) | Benzimidazolderivativer som 5-HT6,5-HT24 | |
NO20063111L (no) | Fremgangsmate for fremstilling av tiazolpyrimidiner | |
NO20043951L (no) | 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler | |
NO20022123L (no) | Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII | |
TW200510361A (en) | Process of preparating 3-acylaminobenzofuran-2-carboxylic acid derivatives | |
NO20052360L (no) | Forbedrede formuleringer inneholdende substituerte imidazolderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |